VistaGen Therapeutics, Inc. (NASDAQ:VTGN)
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) represented a move of 0 percent or $0.06 per share and closed its previous day trading session at $1.79. 0 Shares were traded in the last trading session with an Average Volume of 520.79 Million Shares. The stock currently has a Market Capitalization of 54.99 Million.
VistaGen Therapeutics, Inc. is a biotechnology company. It is engaged in developing and commercializing product candidates for diseases and disorders involving the central nervous system. The company’s lead product candidate consists of AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder. VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
The stock traded between $0.78 and $2.65 over 1-Year time period showing its price to sales ratio of 0. VistaGen Therapeutics, Inc. (NASDAQ:VTGN) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-4.7 and 200-Day Simple Moving Average of $27.74. Its Price to Free Cash Flow is 0 and Price to Book of 11.93.
Analyst’s recommended the stock as 1.7 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, VistaGen Therapeutics, Inc. (NASDAQ:VTGN) reported its Actual EPS of $-0.3/share. The analysts offering Earnings Estimates for the company were believing that VistaGen Therapeutics, Inc. could bring EPS of $-0.17/share. The difference between Actual EPS and Estimated EPS was -0.13 Percent. Thus showing an Earnings Surprise of -76.5 Percent.
Transatlantic Petroleum Ltd (NYSE:TAT)
In the last trading session, Transatlantic Petroleum Ltd (NYSE:TAT) added its value by 0% closing at the price of $1. The stock currently has market capitalization of 51.47 Million, with average volume of 79.27 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Transatlantic Petroleum Ltd (NYSE:TAT) is showing beta of 1.99. This particular value of beta suggests that Transatlantic Petroleum Ltd (NYSE:TAT) has historically moved 199% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Transatlantic Petroleum Ltd (NYSE:TAT) is at $-0.17.
The stock currently has RSI of 40.45. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
TransAtlantic Petroleum Ltd. is a vertically integrated, international oil and gas company. The Company is engaged in the acquisition, development, exploration, and production of crude oil and natural gas. TransAtlantic Petroleum operates in Morocco, Romania, Turkey and California.
Transatlantic Petroleum Ltd (NYSE:TAT) topped its 52-week high price of $2.18 on 02/07/18 and 52-Week Low Price of $0.65 on 11/15/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.89% and monthly volatility of 11.33% respectively.